 (Br_ Ophthalmol 1993; 77: 440-444) 
HSK is a relatively common cause of corneal blindness and may present clinically as a dendritic or amoeboid epithelial ulcer, or as stromal disease manifested by stromal oedema and corneal opacification, or as a combination of epithelial and stromal disease. Immunopathological mechanisms are important in the genesis of clinical stromal HSK and it has been shown that the immune response and clinical disease varies with the strain of virus and the strain of mouse.67 Local immune mechanisms are also involved in the control of epithelial disease since the use of local immunosuppression delays healing of dendritic ulcers and increases the size ofthe ulcer. HSK, in animal models, is known to induce LC infiltration of the cornea.289 In the various animal models of primary HSK studied, LCs infiltrate the cornea during the first 2 weeks following infection with HSV. Since the majority of the infiltrate occurs when HSV antigen can no longer be isolated from the cornea, the role of LC infiltration in presentation of HSV is unclear.
Using a well described mouse model of HSK we studied the expression of Ia antigen on mouse corneal epithelium during HSK over a defined period of time and furthermore we have assessed the ability of corneal epithelium to stimulate a T cell proliferative response to HSV in vitro.
Materials and methods

ANIMALS
Six to eight week old inbred male NIH mice (haplotype H-2q), bred in the departmental animal facility, were used throughout the study.
ANTIGENS
Herpes simplex virus type 1 strain KOS (HSVIKOS, the kind gift of Dr C Shimeld) was used throughout to immunise animals. HSV1 strain SC16 was used to produce clinical HSK and in the lymphocyte proliferation assays (LPA). HSV1 was obtained from a stock pool of HSV1 originally grown on a Vero cell monolayer and stored in 0o 1 to 0 5 ml aliquots at -70°C.
Mock virus was used as a control antigen for immunisation and in the LPA, having been diluted in a similar manner to the virus preparation. It was prepared and stored in the same manner as the stock preparations of HSV, using Vero cells and culture medium, but no HSV was added.
Keyhole limpet haemocyanin (KLH, Calbiochem-Berking, La Jolla, USA), a commonly employed antigen, with a stock concentration of 10 to 20 mg/ml, was prepared and dialysed extensively in phosphate buffered saline (PBS) and pH adjusted to 7-2. It was used at a concentration of 100 jig/ml, as a control for antigen specificity.
IMMUNISATION
Mice were inoculated on the hind foot pad by direct scarification, under general anaesthesia, with 5 1i of live HSV1 strain KOS (2x 108 plaque-forming units (pfu)/ml). HSVlKOS was chosen as the immunising virus because it is known to give good immunity and has minimal neurotoxicity. Control mice were similarly inoculated on the foot pad with mock virus.
CORNEAL INOCULATION
Fourteen days following foot pad inoculation, immune and non-immune mice were inoculated on the left comea by direct scarification through 5 t live HSV1 strain SC16 (4x 108 pfu/ml and 105 pfu/ml respectively).'0 HSVlSC16 was chosen as the corneal inoculating agent because considerable data exist in this laboratory on its associated ocular infection.8'11 12 A larger dose of virus was required to cause significant keratitis in immune compared with non-immune mice.
DEMONSTRATION OF Ia ANTIGEN ON CORNEAL EPITHELIUM
On days 3, 5, and 7 following corneal inoculation, mice were sacrificed, the left eye enucleated, incubated in a solution of 4 mM ethylenediamine tetra-acetic acid (tetra-sodium salt, Sigma Chemical Co, Poole, Dorset) and the epithelial sheet removed.'3 The isolated epithelial sheets were rinsed in PBS and fixed with a 50:50 mixture of acetone and methanol.
Endogenous peroxidase was blocked with 0-06% hydrogen peroxide, the sheets immersed in PBS, and subsequently in normal goat serum (Sera Lab Ltd, Crawley Down, Sussex) (to block non-specific binding sites). The sheets were then immersed in the primary monoclonal antibody, rat anti-mouse immunoglobulin supernatant to Ia antigen, subregion H2, IA at a dilution of 1:10 (Sera Lab Ltd, Crawley Down, Sussex), incubated for 12-24 hours at 4°C and following rinsing, immersed in the horseradish peroxidase linked whole antibody (sheep anti-rat immunoglobulin, dilution 1:100) (Amersham, Bucks) for 2 hours and rinsed again. They were then immersed in a solution made from a diaminobenzidine Isopac (Sigma Chemical Co, Poole, Dorset) for 10 minutes, rinsed, laid out on glass slides, and mounted in Apathys aqueous mount.
CELL PREPARATION
Aseptically excised spleens were minced through a stainless steel mesh into PBS. Spleens from immune mice were removed 9 days following foot pad inoculation with live virus. After the debris was allowed to settle, the cell preparation was decanted off and washed twice in PBS by centrifugation at 1000 rpm. T (2) - (2) The intensity of the Ia antigen staining on the corneal epithelium was greater on day 5 compared with day 3 in both herpetically infected groups but was more intense and diffuse on day 7 in the non-immune mice compared with mice immunised to HSV before corneal inoculation (Table 1) .
No detectable levels of Ia antigen were apparent on corneal epithelium of normal mice (Fig 2) , mice inoculated on the cornea through mock virus, or negative controls where no primary anti-Ia monoclonal antibody was used.
LYMPHOCYTE PROLIFERATIVE RESPONSES
There was a significant increase in the proliferative response of T cells on days 2-7 in culture when corneal epithelium (without LC) was used as the test antigen presenting cell population (Table 2) . On day 4 in vivo HSV primed T cells proliferated in response to HSV, with a stimulation index of 172, when corneal epithelium was added to the cultures. This compared with a stimulation index of 7 when T cells and HSV alone were in culture. The proliferative response was specific to viral components since mock virus, prepared in a similar fashion to the Antigen presentation ofherpes simplex virus by corneal epithelium-an in vitro and in vivo study It is probable that small numbers ofIa negative cells with the potential of becoming APCs were present in the Ia depleted T cell preparations but it is clear that these were unable to stimulate a strong T cell proliferative response since the addition of corneal epithelium to the cultures increased the stimulation index from 7 (for T cells with HSV) to 172 (for cultures with T cells, HSV, and corneal epithelium) after 4 days in culture. For T cell proliferation ofthis magnitude to occur antigen presenting cells and a cytokine co-factor, like IL1, along with antigen is necessary. Since corneal epithelium can produce corneal epithelial cell derived thymocyte activating factor (CETAF) which possesses IL1-like properties22 and we have shown in this study that corneal epithelium can express Ia antigen, these two factors along with HSV antigen are likely to have contributed to the T cell proliferation.
The function of Ia antigen expression on corneal epithelium and of the lymphocyte stimulatory properties of corneal epithelium is unknown but it may be speculated that this property is a manifestation of one component of the overall in vivo immune response involved in T cell activation and therefore subsequent control of a herpetic infection. The 
